Patent ID: 8741358

Claim:
A method of promoting production of ghrelin in a human subject in need thereof, the method comprising administering an effective amount of Rikkunshi-to to the human subject, wherein said Rikkunshi-to comprises 3.0 to 4.0 weight parts of Atractylodes Lancea or Atractylodes, 2.0 to 4.0 weight parts of Ginseng Radix, 3.0 to 4.0 weight parts of Pinelliae Tuber, 3.0 to 4.0 weight parts of Poria Sclerotium , 2.0 weight part of Zizyphi Fructus , 2.0 to 4.0 weight parts of Aurantii Nobilis Pericarpium , 1.0 to 1.5 weight parts of Glycyrrhiza Radix, and 0.5 to 2.0 weight parts of Zingiberis Rhizoma, wherein the human subject in need thereof is suffering from reperfusion injury after bypass surgery, reperfusion injury after percutaneous transluminal coronary angioplasty for myocardial infarction, coronary microcirculation failure, myocarditis, dilated cardiomyopathy, cardiac transplantation, arrhythmia, amyotrophic lateral sclerosis, diabetic neurological disorder, neurological disorder caused by traumatic neural damage, neurological disorder caused by neural deficiency, toxic neurological disorder, multiple sclerosis, vascular dementia, Parkinson's disease, Huntington's disease, or spinal injury.